Analysis of a new human parechovirus allows the definition of parechovirus types and the identification of RNA structural domains

Journal of Virology

Volumn 81, Issue 2, 2007, Pages 1013-1021

  Al Sunaidi, Mohammed ^a   Williams, Çiǧdem H ^a   Hughes, Pamela J ^a   Schnurr, David P ^b   Stanway, Glyn ^a  

^a UNIVERSITY OF ESSEX   (United Kingdom)

^b CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; VIRUS RNA;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HUMAN; HUMAN CELL; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PARECHOVIRUS; PARECHOVIRUS TYPE 1; PARECHOVIRUS TYPE 2; PARECHOVIRUS TYPE 3; PARECHOVIRUS TYPE 4; PARECHOVIRUS TYPE 5; PICORNAVIRUS; PRIORITY JOURNAL; RNA STRUCTURE; SEQUENCE ANALYSIS; SEROTYPE; UNITED STATES; VIRAL GENETICS; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TYPING;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE, TUMOR; ENHANCER ELEMENTS (GENETICS); HUMANS; PARECHOVIRUS; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

HUMAN PARECHOVIRUS; PARECHOVIRUS; PICORNAVIRIDAE;

EID: 33846045617     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00584-06     Document Type: Article

References (51)

1. Abed, Y., and G. Boivin. 2005. Molecular characterization of a Canadian human parechovirus (HPeV)-3 isolate and its relationship to other HPeVs. J. Med. Virol. 77:566-570.
2. Benschop, K. S. M., J. Schinkel, R. P. Minnaar, D. Pajkrt, L. Spanjerberg, H. C. Kraakman, B. Berkhout, H. L. Zaaijer, M. G. H. M. Beld, and K. C. Wolthers. 2006. Human parechovirus infections in Dutch children and the association between serotype and disease severity. Clin. Infect. Dis. 42:204-210.
3. Boivin, G., Y. Abed, and F. D. Boucher. 2005. Human parechovirus 3 and neonatal infections. Emerg. Infect. Dis. 11:103-105.
4. Boonyakiat, Y., P. J. Hughes, F. Ghazi, and G. Stanway. 2001. An arginine-glycine-aspartic acid motif is a critical determinant for human parechovirus 1 entry. J. Virol. 75:10000-10004.
5. Chang, K. H., P. Auvinen, T. Hyypiä, and G. Stanway. 1989. The nucleotide sequence of coxsackievirus A9; implications for receptor binding and enterovirus classification. J. Gen. Virol. 70:3269-3280.
6. Chang, K. H., C. Day, J. Walker, T. Hyypiä, and G. Stanway. 1992. The nucleotide sequences of wild-type coxsackievirus A9 strains imply that an RGD motif in VP1 protein is functionally significant. J. Gen. Virol. 73:621-626.
7. Ehrnst, A., and M. Eriksson. 1993. Epidemiological features of type 22 echovirus infection. Scand. J. Infect. Dis. 25:275-281.
8. Figueroa, J. P., D. Ashley, D. King, and B. Hull. 1989. An outbreak of acute flaccid paralysis in Jamaica associated with echovirus type 22. J. Med. Virol. 29:315-319.
9. Ghazi, F., P. J. Hughes, T. Hyypiä, and O. Stanway. 1998. Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J. Gen. Virol. 79: 2641-2650.
10. Goodfellow, I., Y. Chaudhry, A. Richardson, J. Meredith, J. W. Almond, W. Barclay, and D. J. Evans. 2000. Identification of a cis-acting replication element within the poliovirus coding region. J. Virol. 74:4590-4600.
11. Guindon, S., and O. Gascuel. 2003. A simple, fast, and accurate algorithm to estimate large phytogenies by maximum likelihood. Syst. Biol. 52:696-704.
12. Harvala, H., H. Kalimo, G. Stanway, and T. Hyypiä. 2003. The role of the viral arginine-glycine-aspartic acid motif in the mouse pathogenesis of coxsackievirus A9. J. Gen. Virol. 84:2375-2379.
13. Hughes, P. J., C. Horsnell, T. Hyypiä, and G. Stanway. 1995. The coxsackievirus A9 RGD motif is not essential for virus infectivity. J. Virol. 69:8035-8040.
14. Hughes, P. J., and G. Stanway. 2000. The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev-107 family of proteins involved in the control of cell proliferation. J. Gen. Virol. 80:201-207.
15. Hyypiä, T., C. Horsnell, M. Maaronen, M. Khan, N. Kalkkinen, P. Auvinen, L. Kinnunen, and G. Stanway. 1992. A distinct picornavirus group identified by sequence analysis. Proc. Natl. Acac. Sci. USA 89:8847-8851.
16. Ito, M., T. Yamashita, H. Tsuzuki, N. Takeda, and K. Sakae. 2004. Isolation and identification of a novel human parechovirus. J. Gen. Virol. 85:391-398.
17. Jackson, T., D. Sheppard, M. Denyer, W. Blakemore, and A. M. Q. King. 2000. The epithelial integrin alpha v beta 6 is a receptor for foot-and-mouth disease virus. J. Virol. 74:4949-4956.
18. Johansson, S., B. Niklasson, J. Maizel, A. E. Gorbalenya, and A. M. Lindberg. 2002. Molecular analysis of three Ljungan virus isolates reveals a new, close-to-root lineage of the Picornaviridae with a cluster of two unrelated 2A proteins. J. Virol. 76:8920-8930.
19. Joki-Korpela, P., and T. Hyypiä. 2001. Parechoviruses, a novel group of human picornaviruses. Ann. Med. 33:466-471.
20. Joki-Korpela, P., V. Marjomäki, C. Krogerus, J. Heino, and T. Hyypiä. 2001. Entry of human parechovirus 1. J. Virol. 75:1958-1967.
21. Joki-Korpela, P., M. Roivainen, H. Lankinen, T. Pöyry, and T. Hyypiä. 2000. Antigenic properties of human parechovirus 1. J. Gen. Virol. 81:1709-1718.
22. Krogerus, C., D. Egger, O. Samuilova, T. Hyypiä, and K. Bienz. 2003. Replication complex of human parechovirus 1. J. Virol. 77:8512-8523.
23. Lindberg, A. M., P. Andersson, C. Savolainen, M. N. Mulders, and T. Hovi. 2003. Evolution of the genome of human enterovirus B: incongruence between phytogenies of the VP1 and 3CD regions indicates frequent recombination within the species. J. Gen. Virol. 84:1223-1235.
24. Lobert, P. E., N. Escriou, J. Ruelle, and T. Michiels. 1999. A coding RNA sequence acts as a replication signal in cardioviruses. Proc. Natl. Acad. Sci. USA 96:11560-11565.
25. Lole, K. S., R. C. Bollinger, R. S. Paranjape, D. Gadkari, S. S. Kulkarni, N. G. Novak, R. Ingersoll, H. W. Sheppard, and S. C. Ray. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:152-160.
26. Lukashev, A. N., V. A. Lashkevich, O. E. Ivanova, G. A. Koroleva, A. E. Hinkkanen, and J. Ilonen. 2003. Recombination in circulating enteroviruses. J. Virol. 77:10423-10431.
27. 27. Mason, P. W., S. V. Bezborodova, and T. M. Henry. 2002. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J. Virol. 76: 9686-9694.
28. Mathews, D. H., J. Sabina, M. Zuker, and D. H. Turner. 1999. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure J. Mol. Biol. 288:911-940.
29. Mirmomeni, M., P. J. Hughes, and G. Stanway. 1997. An RNA tertiary structure in the 3′ untranslated region of enteroviruses is necessary for efficient replication. J. Virol. 71:2363-2370.
30. Nateri, A. S., P. J. Hughes, and G. Stanway. 2000. In vivo and in vitro identification of structural and sequence elements of the human parechovirus 5′ untranslated region required for internal initiation. J. Virol. 74:6269-6277.
31. Nateri, A. S., P. J. Hughes, and G. Stanway. 2002. Terminal replication elements in human parechovirus 1. J. Virol. 76:13116-13122.
32. Norder, H., L. Bjerregaard, L. Magnius, B. Lina, M. Aymard, and J. J. Chomel. 2003. Sequencing of 'untypable' enteroviruses reveals two new types, EV-77 and EV-78, within human enterovirus type B and substitutions in the BC loop of the VP1 protein for known types. J. Gen. Virol. 84:827-836.
33. Oberste, M. S., K. Maher, and M. A. Pallansch. 1998. Complete sequence of echovirus 23 and its relationship to echovirus 22 and other human enteroviruses. Virus Res. 56:217-223.
34. Oberste, M. S., K. Maher, D. R. Kilpatrick, M. R. Flemister, B. A. Brown, and M. A. Pallansch. 1999. Typing of human enteroviruses by partial sequencing of VP1. J. Clin. Microbiol. 37:1288-1293.
35. Oberste, M. S., K. Maher, D. R. Kilpatrick, and M. A. Pallansch. 1999. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J. Virol. 73:1941-1948.
36. Oberste, M. S., K. Maher, and M. A. Pallansch. 2004. Evidence for frequent recombination within species human enterovirus B based on complete genomic sequences of all thirty-seven serotypes. J. Virol. 78:855-867.
37. Oberste, M. S., S. M. Michele, K. Maher, D. Schnurr, D. Cisterna, N. Junttila, M. Uddin, J.-J. Chomel, C-S Lau, W. Ridha, S. al-Busaidy, H. Norder, L. O. Magnius, and M. A. Pallansch. 2004. Molecular identification and characterization of two proposed new enterovirus serotypes. EV74 and EV75. J. Gen. Virol. 85:3205-3212.
38. Paul, A. V., E. Rieder, D. W. Kim, J. H. van Boom, and E. Wimmer. 2000. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J. Virol. 74:10359-10370.
39. Samuilova, O., C. Krogerus, I. Fabrichniy, and T. Hyypiä. 2006. ATP hydrolysis and AMP kinase activities of nonstructural protein 2C of human parechovirus 1. J. Virol. 80:1053-1058.
40. Santti, J., T. Hyypiä, L. Kinnunen, and M. Salminen. 1999. Evidence of recombination among enteroviruses. J. Virol. 73:8741-8749.
41. Schnurr, D., M. Dondero, D. Holland, and J. Connor. 1996. Characterization of echovirus 22 variants. Arch. Virol. 141:1749-1758.
42. Stanway, G., F. Brown, P. Christian, T. Hovi, T. Hyypiä, A. M. Q. King, N. J. Knowles, S. M. Lemon, P. D. Minor, M. A. Pallansch, A. C. Palmenberg, and T. Skern. 2004. Picornaviridae, p. 757-778. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy, VIIIth report of the ICTV. Elsevier/Academic Press, London, United Kingdom.
43. Stanway, G., N. Kalkkinen, M. Roivainen, F. Ghazi, M. Khan, M. Smyth, O. Meurman, and T. Hyypiä. 1994. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J. Virol. 68:8232-8238.
44. Stanway, G., and T. Hyypiä. 1999. Parechoviruses. J. Virol. 73:5249-5254.
45. Stanway, G., P. Joki-Korpela, and T. Hyypiä. 2000. Human parechoviruses-biological and clinical significance. Rev. Med. Virol. 10:57-69.
46. Stanway, G., T. Hovi, N. J. Knowles, and T. Hyypiä. 2002. Biological and molecular basis of picornavirus classification, p. 17-24. In B. L. Semler and E. Wimmer (ed.), Molecular biology of picornaviruses. ASM Press, Washington, DC.
47. Stewart, S. R., and B. L. Semler. 1997. RNA determinants of picornavirus cap-independent translation initiation. Semin. Virol. 8:242-255.
48. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
49. Williams, Ç. H., T. Kajander, T. Hyypiä, T. Jackson, D. Sheppard, and G. Stanway. 2004. Integrin αvβ6 is an RGD-dependent receptor for coxsackievirus A9. J. Virol. 78:6967-6973.
50. Yang, Y., R. Rijnbrand, K. L. McKnight, E. Wimmer, A. Paul, A. Martin, and S. M. Lemon. 2002. Sequence requirements for viral RNA replication and VPg uridylylation directed by the internal cis-acting replication element (cre) of human rhinovirus type 14. J. Virol. 76:7485-7494.
51. Zuker, M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31:3406-3415.